| ²é¿´: 389 | »Ø¸´: 2 | ||
ÇîÈËÒ²¿ìÀÖ½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÎÄÏ×ÇóÖú£¬ÇóÈ«ÎÄ£¬ÌâÄ¿ÔÚÕýÎÄ£¬Íò·Ö¸Ð¼¤ ÒÑÓÐ1È˲ÎÓë
|
|
P-134Safety and efficacy of low-dose decitabine primed chemotherapy in patients with chemoresistant relapsed/refractory gastrointestinal cancers ÎÄÏ×ÇóÖú£¬ÇóÈ«ÎÄ£¬Íò·Ö¸Ð¼¤ ![]() |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ52È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
Áôѧ--²©Ê¿ÕÐÉú
ÒѾÓÐ16È˻ظ´
»¯Ñ§¹¤³Ì£¬±¾211£¬Çóµ÷¼Á£¬abÇø²»ÏÞ
ÒѾÓÐ4È˻ظ´
ÉÛÑôѧԺʳƷÓ뻯ѧ¹¤³ÌѧԺ˶ʿµ÷¼Á
ÒѾÓÐ0È˻ظ´
ºþ±±Ê¦·¶´óѧÕе÷¼ÁÀ²
ÒѾÓÐ2È˻ظ´
smyli
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
ÈÕÔµ±¿Õ•×
- Ó¦Öú: 89 (³õÖÐÉú)
- ½ð±Ò: 13974.5
- É¢½ð: 1726
- ºì»¨: 39
- ɳ·¢: 1
- Ìû×Ó: 5407
- ÔÚÏß: 826.5Сʱ
- ³æºÅ: 1132835
- ×¢²á: 2010-10-27
- ÐÔ±ð: GG
- רҵ: Ó¦Óø߷Ö×Ó»¯Ñ§ÓëÎïÀí
2Â¥2017-10-12 14:46:17
xushangwei
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 107.8
- É¢½ð: 25
- Ìû×Ó: 33
- ÔÚÏß: 7.6Сʱ
- ³æºÅ: 3282219
- ×¢²á: 2014-06-16
- רҵ: »·¾³Î¢ÉúÎïѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
| ÄãºÃ£¬ÊÇÕâÆªÂ𣿠|
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : mdx261.133.pdf
2017-10-12 16:30:20, 255.68 K
3Â¥2017-10-12 16:31:05















»Ø¸´´ËÂ¥